Gradual titration and extended release formulation should reduce adverse effects
New study explores intensification inertia in patients with diabetes and above-goal A1C levels
An inexpensive pharmaceutical that improves glycemic control is underused
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Largest series of its kind to date
Should we focus on the sugar or the weight?
Benefits even those with severe type 2 diabetes
Biomarkers urgently needed
$10.2M NIH grant supports long-term study
Diabetes is hard for adults, even harder for children
